Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in LSTA — Lisata Therapeutics, Inc.

CIK 70858 CHARLOTTE, NC
Back to LSTA Full portfolio

Position in LSTA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$35,200
-$16,668 QoQ
Shares Held
10,353
0.0% QoQ
Ownership
0.115%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 31 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LSTA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. LSTA ranks #325 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in LSTA

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $35,200 10,353
2026-03-31 $51,868 10,353
2025-12-31 $19,376 10,418
2025-09-30 $27,291 10,417
2025-06-30 $30,220 10,421
2025-03-31 $24,470 10,413
2024-12-31 $31,020 10,410
2024-09-30 $29,145 9,715
2024-06-30 $33,703 9,713
2024-03-31 $30,132 9,658
2023-12-31 $26,376 9,662
2023-09-30 $20,723 9,684
2023-06-30 $96 26
2023-03-31 $84 26
2022-12-31 $115 46
2022-09-30 $147 32